Mount Yale Investment Advisors’s Gilead Sciences GILD Stock Holding History

Mount Yale Investment Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.5M	Buy	25,126 +19,758	+368%	+$2.77M	0.08%	249
2025 Q4	$659K	Buy	5,368 +3,141	+141%	+$382K	0.03%	391
2025 Q3	$247K	Buy	2,227 +1,226	+122%	+$139K	0.02%	566
2025 Q2	$111K	Buy	+1,001	New	+$107K	0.01%	634
2022 Q4	–	Sell	-119,749	Closed	-$7.39M	–	473
2022 Q3	$7.39M	Buy	119,749 +10,154	+9%	+$640K	0.98%	11
2022 Q2	$6.77M	Buy	109,595 +3,596	+3%	+$223K	0.85%	15
2022 Q1	$6.3M	Buy	+105,999	New	+$6.78M	0.69%	26
2018 Q4	–	Sell	-4,559	Closed	-$330K	–	493
2018 Q3	$330K	Sell	4,559 -5,287	-54%	-$399K	0.06%	237
2018 Q2	$697K	Buy	9,846 +5,132	+109%	+$362K	0.13%	138
2018 Q1	$355K	Buy	+4,714	New	+$375K	0.08%	228

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Mount Yale Investment Advisors's GILD Position: Q1 2026 in Review

Mount Yale Investment Advisors increased its Gilead Sciences (GILD) stake by 368% in Q1 2026, buying an estimated $2.77M and bringing the position to 25,126 shares worth $3.5M. The position accounts for 0.08% of the portfolio, ranked #249.

Mount Yale Investment Advisors first reported a position in GILD in Q1 2018 and has held it in 10 quarters since. The position peaked at $7.39M in Q3 2022. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Mount Yale Investment Advisors held 25,126 shares of Gilead Sciences worth $3.5M as of Q1 2026.
Mount Yale Investment Advisors bought 19,758 Gilead Sciences shares in Q1 2026, an estimated $2.77M.
Gilead Sciences made up 0.08% of Mount Yale Investment Advisors's portfolio in Q1 2026, its #249 holding.
Mount Yale Investment Advisors first reported a position in Gilead Sciences in Q1 2018 and has held it in 10 quarters since.
Mount Yale Investment Advisors's Gilead Sciences position peaked at $7.39M in Q3 2022.
2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Mount Yale Investment Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.